SMARCC1 and experimental autoimmune encephalomyelitis: We previously demonstrated that ubiquitous SRG3 overexpression downregulates pro-inflammatory DC activation and promotes anti-inflammatory M2 differentiation, consequently resulting in amelioration of experimental autoimmune encephalomyelitis (EAE) [6].